This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation. Radiation therapy uses radiation beams made of photons, protons, heavy-ions, and other particles. These radiation beams of intense energy are used to destroy or shrink cancer/tumor cells.
The term ‘radiation therapy’ mostly refers to external beam radiation therapy, but it also means internal beam radiation therapy too. The external beam radiation therapy is done with the help of a machine outside the patient’s body that produces a high-energy radiation beam and then aims the beam to a localized precise point or area of treatment on the patient’s body. Whereas internal beam radiation therapy is a method to place radiation (radioactive source) inside the patient’s body.
The radiation therapy systems (machines) available in the market are, namely, linear accelerator (LINAC), cyclotrons, synchrotrons, synchrocyclotrons, and conventional and electronic brachytherapy systems.
The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.0% during the forecast period from 2021 to 2031.
Market Segmentation
- Radiation - External Beam Radiation, Internal Beam Radiation
- Product - Oncology Systems, Particle Therapy Systems (Proton and Heavy-Ion), Others
- Therapy - Stereotactic Radiosurgery (SRS), Brachytherapy, Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Volumetric-Modulated Arc Therapy (VMAT)
- End User - Hospitals & Medical Research Institutes, Specialized Radiotherapy Centers (SRCs)
- Region - North America, Europe, Asia-Pacific, Rest-of-the-World
Regional Segmentation
- North America - U.S., Canada
- Europe - Germany, France, Spain, U.K., Italy, Rest-of-Europe
- Asia-Pacific - Japan, South Korea, India, China, Australia and New Zealand, Rest-of-Asia-Pacific
- Rest-of-the-World
Market Growth Drivers
- Rising Incidence and Prevalence of Neoplastic Patients and Elevating Geriatric Population
- Rising Demand for Reduced Radiation Exposure During Radiotherapy
- Technological Advancements in the Field of Radiotherapy
Market Challenges
- High Cost of Radiotherapy Systems and their Associated Procedures
- Highly Regulated Market due to the Use of Radiation
Market Opportunities
- Development of Low-Cost Cancer Treatment Center
- Implementation of Machine Learning in Radiotherapy Systems
Key Companies Profiled
Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Ltd.
Who should buy this report?
- Radiation Therapy Systems Parts OEMs
- Accelerator Manufacturers
- Radiation Therapy Systems Manufacturers
- Software Developers
- Imaging Modalities (MRI, CT, PET, Ultrasound, among others) Manufactures
Key Questions Answered in the Report
- Which are the consortiums in the radiation therapy market, and what is their role in the market?
- How is the funding scenario in the radiation therapy market?
- What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?
- What is the market trend within the radiation therapy systems industry?
- What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?
- How will the industry evolve during the forecast period 2021-2031?
- What are the key developmental strategies implemented by the key players to sustain in the competitive market?
- What is the current market share of each of the companies in the global radiation therapy in oncology market and what will be their contribution in 2031?
- What is the growth potential of radiation therapy in oncology market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
- What are the key regulatory implications in developed and developing regions for radiation therapy systems and associated procedures?
Radiation Therapy Market Drivers
Presently, the factors driving the growth of the market as per the radiation therapy report include rising incidence and prevalence of neoplastic patients, elevating geriatric population, rising demand for reduced radiation exposure during radiotherapy, technological advancements in the field of radiotherapy.
All the radiation therapy systems, such as external beam radiation systems or internal beam radiation systems are based on using radiation beams to treat cancer/tumor. The radiation beam destroys the cell’s DNA thus, resulting in the shrinkage or destruction of the cancer/tumor. This cancer/tumor treatment by radiation beam has resolved treatment of complex cancer/tumor and providing less side effects when compared to traditional radiation therapy by x-ray or cobalt-60, or chemotherapy.
Radiation Therapy Market Challenges
The challenges that are restricting the growth of the market include the high cost of radiotherapy systems and their associated procedures, and a highly regulated market due to the use of radioactivity.
The high cost of the systems and their associated procedures are among the most challenging factors for the end-user to buy and treatment delivery for patients. It has been observed that many patients prefer international travel for their treatment to take the advantage of the currency rate. Also, the highly regulated market because of the use of radioactivity has led the company to strictly obey the regulations to commercialize their products. Lack of accuracy in beam or radiation dose delivery is another factor affecting the growth of global radiation therapy in the oncology market.
Radiation Therapy Market Opportunities
Potential opportunities that are likely to boost the growth of the market include the development of low-cost cancer treatment centers, the development of a radiation therapy system which is cost effective, and implementation of machine learning in the radiation therapy system.
The current radiation therapy systems have a price of more than $2 million, therefore many companies are working in developing cost-effective systems and even working towards the development of a low-cost infrastructure facility for radiation therapy. And with time, technologically advanced products are being worked on, researched to get an upgraded product.
Impact of COVID-19 on Radiation Therapy Market
The neoplastic patients were at concern with their need for timely diagnosis, treatment, and symptom palliation due to the pandemic lockdown. During the pandemic, there was an increased number of treatments for some cancers and on the other hand, some radiotherapy treatments fell significantly. The increase in the number of cancer treatments via radiation therapy was due to reduced surgical procedures, which lead the doctors to give radiation therapy as an alternative solution for the surgery.
In response to safety from the COVID-19 virus. professional bodies internationally issued guidance for cancer care. The suggestions were treatment omission or delay, utilizing radiation therapy to replace or to bridge to surgery, and use of short and high-daily-dose (HDR or hypo-fractionated) radiotherapy.
Market Segmentation
Radiation Therapy Market (by Radiation Type)
Under this segmentation, the radiation therapy market is divided into external beam radiation and internal beam radiation.
The external beam radiation segment dominates the market with a share of 82.8% of the global radiation therapy market mainly due to the more treatment processes being conducted by external beam radiation therapy systems.
The internal beam radiation segment is expected to register a higher CAGR than the external beam radiation segment, the CAGR is 6.7% during the forecast period.
Radiation Therapy Market (by Product Type)
Under this segmentation, the radiation therapy market is divided into oncology systems, particle therapy systems (proton and heavy-ion), and others.
The oncology systems segment which consists of traditional radiation therapy systems (x-ray, gamma, cobalt-60 external beam radiation therapy systems, and internal beam radiation therapy systems, among others) dominates the radiation therapy market with a share of 81.9% of the global radiation therapy market mainly due to the number of installed bases of traditional systems and internal beam radiation therapy systems, the number of procedures being conducted, and the cost of the systems and the procedure when compared with the proton or heavy-ion radiation therapy systems.
The particle therapy systems (proton and heavy-ion) segment is expected to register a higher CAGR of 7.5% during the forecast period.
Radiation Therapy Market (by Therapy)
Under this segmentation, the radiation therapy market in divided into stereotactic radiosurgery (SRS), brachytherapy, image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT).
The stereotactic radiosurgery (SRS) segment dominates the radiation therapy market with a share of 40% of the global market mainly due to the number of procedures being performed by the surgeons and clinicians.
The volumetric-modulated arc therapy segment is expected to register a higher CAGR of 6.8% during the forecast period.
Radiation Therapy Market (by End-User)
Under this segmentation, the radiation therapy market in divided into hospitals and medical research institutes, and specialized radiotherapy centers (SRCs).
The hospitals and medical research institutes segment dominates the radiation therapy market with a share of 84.5% of the global market mainly due to the number of hospitals, medical and research institutes providing access to radiotherapy for the patients.
The specialized radiotherapy centers (SRCs) segment is expected to register a higher CAGR of 6.2% during the forecast period.
Radiation Therapy Market (by Region)
The different regions covered under the radiation therapy in oncology market report include North America, Europe, Asia-Pacific, and Rest-of-the-World.
North America dominated the radiation therapy market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.
The Asia-Pacific market is expected to grow with a higher CAGR of 5.8% during the forecast period.
Key Market Players and Competition Synopsis
Some of the key players operating in the market, include Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Inc.
The radiation therapy market has witnessed several strategic and technological developments in the past four years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are product development and upgradations, partnerships, collaborations, business expansions, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been partnerships, collaborations, and business expansions.
Table of Contents
1 Market Definition
1.1 Assumptions and Limitations
1.2 Market Forecasting Factors
2 Markets
2.1 Market Introduction
2.2 Key Findings and Opportunity Assessment
2.3 Global Market Outlook
2.4 Regulatory Framework
2.4.1 U.S.
2.4.2 Europe
2.4.3 Japan
2.4.4 China
2.4.5 Other Consortiums
2.5 Distribution and Marketing Strategies
2.5.1 Case Study: Elekta AB
2.5.2 Case Study: Varian Medical Systems Inc. (Siemens Healthineers AG)
2.6 Impact of COVID-19 Pandemic on the Market
2.7 Key Developments and Strategies
2.7.1 Partnerships, Alliances, and Business Expansion Activities
2.7.2 Regulatory and Legal Activities
2.7.3 Product Launches and Upgradation
2.7.4 Funding Activities
2.7.5 Mergers and Acquisition Activities
2.8 Market Share Analysis
2.8.1 by Radiation Type
2.8.2 by Product Type
2.8.3 by Therapy
2.8.4 by End User
2.8.5 by Region
2.9 Market Dynamics
2.9.1 Overview
2.9.2 Impact Analysis
2.9.3 Market Drivers
2.9.3.1 Rising Incidence and Prevalence of Neoplastic Patients and Elevating Geriatric Population
2.9.3.2 Rising Demand for Reduced Radiation Exposure During Radiotherapy
2.9.3.3 Technological Advancements in the Field of Radiotherapy
2.9.4 Market Restraints
2.9.4.1 High Cost of Radiotherapy Systems and their Associated Procedures
2.9.4.2 Highly Regulated Market Due to the Use of Radiation
2.9.5 Market Opportunities
2.9.5.1 Development of Low-Cost Cancer Treatment Center
2.9.5.2 Implementation of Machine Learning in Radiotherapy Systems
2.9.6 Market Trend
2.9.6.1 Integration of MRI or CT Technology with Radiotherapy Systems
2.9.6.2 Adoption of Radiation Therapy by Emerging Countries
2.1 Analyst Perspective
2.11 Epidemiology Assessment
3 Application
3.1 Radiation Type
3.1.1 Market Overview
3.1.2 Market Attractiveness Analysis
3.1.3 Market Size and Forecast
3.1.3.1 External Beam Radiation
3.1.3.2 Internal Beam Radiation
3.2 Therapy
3.2.1 Market Overview
3.2.2 Market Attractiveness Analysis
3.2.3 Market Size and Forecast
3.2.3.1 Stereotactic Radiosurgery
3.2.3.2 Image-Guided Radiation Therapy
3.2.3.3 Intensity-Modulated Radiation Therapy
3.2.3.4 Volumetric-Modulated Arc Therapy
3.2.3.5 Brachytherapy
3.3 End User
3.3.1 Market Overview
3.3.2 Market Attractiveness Analysis
3.3.3 Market Size and Forecast
3.3.3.1 Hospitals and Medical Research Institutes
3.3.3.2 Specialized Radiotherapy Centers
4 Products
4.1 Market Overview
4.2 Market Attractiveness Analysis
4.2.1 Market Size and Forecast
4.2.1.1 Oncology Systems
4.2.1.2 Particle Therapy Systems (Proton and Heavy Ion)
4.2.1.3 Others
5 Region
5.1 Market Overview
5.1.1 Market Attractiveness Analysis
5.2 North America
5.2.1 Overview
5.2.1.1 Market Size and Forecast
5.2.1.1.1 Radiation Type
5.2.1.1.2 Product Type
5.2.1.1.3 Country
5.2.1.1.3.1 U.S.
5.2.1.1.3.2 Canada
5.3 Europe
5.3.1 Overview
5.3.1.1 Market Size and Forecast
5.3.1.1.1 Radiation Type
5.3.1.2 Product Type
5.3.1.3 by Country
5.3.1.3.1 Germany
5.3.1.3.2 France
5.3.1.3.3 Italy
5.3.1.3.4 U.K.
5.3.1.3.5 Spain
5.3.1.3.6 Rest-of-Europe
5.4 Asia-Pacific
5.4.1 Overview
5.4.1.1 Market Size and Forecast
5.4.1.2 Radiation Therapy
5.4.1.3 Product Type
5.4.1.4 Country
5.4.1.4.1 Japan
5.4.1.4.2 China
5.4.1.4.3 India
5.4.1.4.4 South Korea
5.4.1.4.5 Australia and New Zealand
5.4.1.4.6 Rest-of-Asia-Pacific
5.5 Rest-of-the-World
5.5.1 Overview
5.5.1.1 Market Size and Forecast
5.5.1.2 Radiation Type
5.5.1.3 Product Type
6 Markets - Competitive Benchmarking & Company Profiles
6.1 Overview
6.1.1 Key Players: Snapshot
6.1.2 Key Strategies Implemented by Market Players
6.2 Accuray Inc.
6.2.1 Company Overview
6.2.2 Role of the Company in the Market
6.2.3 Financials
6.2.4 SWOT Analysis
6.3 Eckert & Ziegler AG
6.3.1 Company Overview
6.3.2 Role of the Company in the Market
6.3.3 Financials
6.3.4 SWOT Analysis
6.4 Elekta AB
6.4.1 Company Overview
6.4.2 Role of the Company in the Market
6.4.3 Financials
6.4.4 SWOT Analysis
6.5 General Electric Company
6.5.1 Company Overview
6.5.2 Role of the Company in the Market
6.5.3 Financials
6.5.4 SWOT Analysis
6.6 Hitachi, Ltd.
6.6.1 Company Overview
6.6.2 Role of the Company in the Market
6.6.3 Financials
6.6.4 SWOT Analysis
6.7 Ion Beam Applications SA
6.7.1 Company Overview
6.7.2 Role of the Company in the Market
6.7.3 Financials
6.7.4 SWOT Analysis
6.8 Koninklijke Philips N.V.
6.8.1 Company Overview
6.8.2 Role of the Company in the Market
6.8.3 Financials
6.8.4 SWOT Analysis
6.9 Mevion Medical Systems Inc.
6.9.1 Company Overview
6.9.2 Role of the Company in the Market
6.9.3 SWOT Analysis
6.1 TeamBest Group
6.10.1 Company Overview
6.10.2 Role of the Company in the Market
6.10.3 SWOT Analysis
6.11 Reflexion Medical Inc.
6.11.1 Company Overview
6.11.2 Role of the Company in the Market
6.11.3 SWOT Analysis
6.12 Sensus Healthcare Inc.
6.12.1 Company Overview
6.12.2 Role of the Company in the Market
6.12.3 Financials
6.12.4 SWOT Analysis
6.13 Varian Medical Systems Inc. (Siemens Healthineers AG)
6.13.1 Company Overview
6.13.2 Role of the Company in the Market
6.13.3 Financials
6.13.4 SWOT Analysis
6.14 Xoft Inc. (iCAD Inc.)
6.14.1 Company Overview
6.14.2 Role of the Company in the Market
6.14.3 Financials
6.14.4 SWOT Analysis
6.15 Xstrahl Inc.
6.15.1 Company Overview
6.15.2 Role of the Company in the Market
6.15.3 SWOT Analysis
6.16 Zap Surgical Systems Inc.
6.16.1 Company Overview
6.16.2 Role of the Company in the Market
6.16.3 SWOT Analysis
7 Research Methodology
7.1 Primary Research
7.2 Secondary Research
7.3 Data Sources and Categorization
7.4 Market Estimation and Forecast Methodology
7.4.1 Top-Down Approach
7.4.2 Bottom-Up Approach
7.5 Data Triangulation
List of Figures
Figure 1: Global Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 2: Dominating Segments of Global Radiation Therapy in the Oncology Market, 2020 and 2031
Figure 3: Global Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020, 2026, and 2031
Figure 4: Global Radiation Therapy in the Oncology Market (by Product Type), 2020, 2026, and 2031
Figure 5: Global Radiation Therapy in the Oncology Market (by Therapy), 2020, 2026, and 2031
Figure 6: Global Radiation Therapy in the Oncology Market (by End User), $Million, 2020, 2026, and 2031
Figure 7: Global Radiation Therapy in the Oncology Market (by Region), $Million, 2020 and 2031
Figure 8: Share of Key Developments and Strategies (by Category), January 2017-March 2021
Figure 9: Figure: Global Radiation Therapy in the Oncology: Market Segmentation
Figure 10: Global Radiation Therapy in the Oncology Market: Incremental Revenue Opportunity, $Million, 2020-2031
Figure 11: Global Radiation Therapy in the Oncology Market Scenario, $Million, 2020-2031
Figure 12: Regulatory Process for Medical Devices in the U.S.
Figure 13: MDR Transitional Provisions (EU)
Figure 14: Regulatory Process for Medical Devices in European Union
Figure 15: Regulatory Process for Medical Devices in China
Figure 16: Global Radiation Therapy in the Oncology Market: Key Developments and Strategies, January 2017-May 2021
Figure 17: Share of Key Developments and Strategies in the Global Radiation Therapy in the Oncology Market (by Category), January 2017-May 2021
Figure 18: Global Radiation Therapy in the Oncology Market – Key Partnerships, Alliances, and Business Expansion Activities, (by Company), 2017-2021
Figure 19: Global Radiation Therapy in the Oncology Market – Key Regulatory and Legal Activities, 2017-2021
Figure 20: Global Radiation Therapy in the Oncology Market – Key New Offerings, 2017-2021
Figure 21: Global Radiation Therapy in the Oncology Market – Key Funding Activities, 2017-2021
Figure 22: Global Radiation Therapy in the Oncology Market, Funding Scenario, $Million, 2005-2021
Figure 23: Global Radiation Therapy in the Oncology Market – Key Mergers and Acquisition Activities, 2017-2021
Figure 24: Global Radiation Therapy in the Oncology Market (by Radiation Type), 2020
Figure 25: Global Radiation Therapy in the Oncology Market (by Product Type), 2020
Figure 26: Global Radiation Therapy in the Oncology Market (by Therapy), 2020
Figure 27: Global Radiation Therapy in the Oncology Market (by End User), 2020
Figure 28: Global Radiation Therapy in the Oncology Market (by Region), 2020
Figure 29: Market Dynamics
Figure 30: Rising Incidence of Neoplastic Persons (Worldwide), 2010-2031
Figure 31: Rising Prevalence of Neoplastic Persons (Worldwide) (by Age Group), 2010-2031
Figure 32: Relative Dose vs. Tissue Depth for Various Particle and Photon Beams
Figure 33: Rising Incidence, Prevalence, and Deaths Caused by Neoplasm (Global), 2010-2019
Figure 34: Market Segmentation: by Radiation Type
Figure 35: Pros and Cons of External and Internal Beam Radiation
Figure 36: Global Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031
Figure 37: Market Attractiveness Analysis (by Radiation Type), 2020-2031
Figure 38: Benefits of Modern External Beam Radiation Therapy
Figure 39: Global Radiation Therapy in the Oncology Market (External Beam Radiation), $Million, 2020-2031
Figure 40: Benefits of Modern Internal Beam Radiation Therapy
Figure 41: Global Radiation Therapy in the Oncology Market (Internal Beam Radiation), $Million, 2020-2031
Figure 42: Market Segmentation: by Therapy
Figure 43: Market Attractiveness Analysis (by Therapy), 2020-2031
Figure 44: Global Radiation Therapy in the Oncology Market (SRS), $Million, 2020-2031
Figure 45: Global Radiation Therapy in the Oncology Market (IGRT), $Million, 2020-2031
Figure 46: Global Radiation Therapy in the Oncology Market (IMRT), $Million, 2020-2031
Figure 47: Global Radiation Therapy in the Oncology Market (VMAT), $Million, 2020-2031
Figure 48: Global Radiation Therapy in the Oncology Market (Brachytherapy), $Million, 2020-2031
Figure 49: Market Segmentation: by End User
Figure 50: Global Radiation Therapy in the Oncology Market (by End User), $Million, 2020-2031
Figure 51: Market Attractiveness Analysis (by End User), 2020-2031
Figure 52: Global Radiation Therapy in the Oncology Market (Hospitals and Medical Research Institutes), $Million, 2020-2031
Figure 53: Global Radiation Therapy in the Oncology Market (SRCs), $Million, 2020-2031
Figure 54: Market Segmentation: by Product Type
Figure 55: Global Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031
Figure 56: Market Attractiveness Analysis (by Product Type), 2020-2031
Figure 57: Global Radiation Therapy in the Oncology Market (Oncology Systems), $Million, 2020-2031
Figure 58: Global Radiation Therapy in the Oncology Market (Particle Therapy Systems (Proton and Heavy Ion)), $Million, 2020-2031
Figure 59: Global Radiation Therapy in the Oncology Market (Others), $Million, 2020-2031
Figure 60: Global Radiation Therapy in the Oncology Market Scenario (by Region), 2020 and 2031
Figure 61: Global Radiation Therapy in the Oncology Market (by Region), 2020 and 2031
Figure 62: Market Attractiveness Analysis (by Region), 2020-2031
Figure 63: North America Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 64: North America Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031
Figure 65: North America Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031
Figure 66: North America Radiation Therapy in the Oncology Market (by Country), 2020-2031
Figure 67: U.S. Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 68: Canada Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 69: Europe Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 70: Europe Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031
Figure 71: Europe Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031
Figure 72: Europe Radiation Therapy in the Oncology Market (by Country), 2020-2031
Figure 73: Germany Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 74: France Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 75: Italy Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 76: U.K. Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 77: Spain Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 78: Rest-of-Europe Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 79: Asia-Pacific Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 80: Asia-Pacific Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031
Figure 81: Asia-Pacific Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031
Figure 82: Asia-Pacific Radiation Therapy in the Oncology Market (by Country), 2020-2031
Figure 83: Japan Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 84: China Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 85: India Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 86: South Korea Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 87: Australia and New Zealand Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 88: Rest-of-Asia-Pacific Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 89: Rest-of-the-World Radiation Therapy in the Oncology Market, $Million, 2020-2031
Figure 90: Rest-of-the-World Radiation Therapy in the Oncology Market (by Radiation Type), $Million, 2020-2031
Figure 91: Rest-of-the-World Radiation Therapy in the Oncology Market (by Product Type), $Million, 2020-2031
Figure 92: Total Number of Companies Profiled
Figure 93: Accuray, Inc.: Overall Financials, $Million, 2018-2020
Figure 94: Accuray Inc.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 95: Accuray Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 96: Eckert & Ziegler Group: Overall Financials, $Million, 2018-2020
Figure 97: Eckert & Ziegler Group: Net Revenue (by Product Type), $Million, 2018-2020
Figure 98: Eckert & Ziegler Group: Net Revenue (by Region), $Million, 2018-2020
Figure 99: Elekta AB: Overall Financials, $Million, 2018-2020
Figure 100: Elekta AB: Net Revenue (by Product Type), $Million, 2018-2020
Figure 101: Elekta AB: Net Revenue (by Region), $Million, 2018-2020
Figure 102: General Electric Company: Overall Financials, $Million, 2018-2020
Figure 103: General Electric Company: Net Revenue (by Product Type), $Million, 2018-2020
Figure 104: General Electric Company (by Healthcare Segment), $Million, 2018-2020
Figure 105: General Electric Company: Net Revenue (by Region), $Million, 2018-2020
Figure 106: Hitachi, Ltd.: Overall Financials, $Million, 2018-2020
Figure 107: Hitachi, Ltd.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 108: Hitachi, Ltd.: Net Revenue (by Region), $Million, 2018-2020
Figure 109: Ion Beam Applications Group: Overall Financials, $Million, 2018-2020
Figure 110: Ion Beam Applications Group: Net Revenue (by Product Type), $Million, 2018-2020
Figure 111: Ion Beam Applications Group: Net Revenue (Medical Devices) (by Region), $Million, 2018-2020
Figure 112: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020
Figure 113: Koninklijke Philips N.V.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 114: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020
Figure 115: Sensus Healthcare Inc.: Overall Financials, $Million, 2018-2020
Figure 116: Sensus Healthcare Inc.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 117: Sensus Healthcare Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 118: Varian Medical Systems Inc.: Overall Financials, $Million, 2018-2020
Figure 119: Varian Medical Systems Inc.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 120: Varian Medical Systems Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 121: iCAD Inc.: Overall Financials, $Million, 2018-2020
Figure 122: iCAD Inc.: Net Revenue (by Product Type), $Million, 2018-2020
Figure 123: Figure: iCAD Inc.: Net Revenue (by Region), $Million, 2018-2020
Figure 124: Research Methodology
Figure 125: Primary Research
Figure 126: Secondary Research
Figure 127: Top-Down Approach
Figure 128: Bottom-Up Approach
Figure 129: Data Triangulation
List of Tables
Table 1: Global Radiation Therapy in the Oncology Market: Impact Analysis
Table 2: Global Radiation Therapy in the Oncology Market: Forecasting Factors
Table 3: Other Organizations/Associations
Table 4: Impact Analysis: Market Drivers
Table 5: Impact Analysis: Market Restraints
Table 6: Number and Distribution of Persons Aged 60 Years or Over (by Region), 2017 and 2050
Table 7: Incidence and Distribution of Different Neoplasm, Million, 2010-2019
Table 8: Global Radiation Therapy in the Oncology Market (by Therapy), $Million, 2020-2031
Table 9: Key Players: Snapshot
Table 10: Key Strategies Implemented by Key Market Players (January 2017-May 2021)
Table 11: Eckert & Ziegler Group: Net Revenue (by Product Category), $Million, 2018-2020
Table 12: Ion Beam Applications Group: Net Revenue (by Product Category), $Million, 2018-2020
Table 13: Varian Medical Systems Inc.: Net Revenue (by Sales Category), $Million, 2018-2020
Table 14: Varian Medical Systems Inc.: Net Revenue (by Region), $Million, 2018-2020
Table 15: iCAD Inc.: Net Revenue (by Product Category), $Million, 2018-2020
Samples
LOADING...
Companies Mentioned
- Accuray Inc.
- Eckert & Ziegler AG
- Elekta AB
- General Electric Company
- Hitachi, Ltd.
- Ion Beam Applications SA
- Koninklijke Philips N.V.
- Mevion Medical Systems Inc.
- Reflexion Medical Inc.
- Sensus Healthcare Inc.
- TeamBest Group
- Varian Medical Systems Inc. (Siemens Healthineers AG)
- Xoft Inc. (iCAD Inc.)
- Xstrahl Inc.
- Zap Surgical Systems Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 203 |
| Published | July 2021 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 5647.7 Million |
| Forecasted Market Value ( USD | $ 9206.6 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
